|
|
|
|
| LEADER |
03572nam a22003855i 4500 |
| 001 |
000293600 |
| 005 |
20211008081017.0 |
| 007 |
cr nn 008mamaa |
| 008 |
170913s2017 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783319591926
|
| 024 |
7 |
|
|a 10.1007/978-3-319-59192-6
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Science of Ashwagandha: Preventive and Therapeutic Potentials /
|c edited by Sunil C. Kaul, Renu Wadhwa.
|
| 250 |
|
|
|a 1st ed. 2017.
|
| 260 |
# |
# |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2017.
|
| 300 |
|
|
|a XX, 508 p. 102 illus., 76 illus. in color. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a PART I Ashwagandha - Phytogenomics and Pharmacology -- Phytochemical Genomics of Ashwagandha -- Phyto-pharmacology of Ashwagandha as An Anti-Diabetic Herb -- Allium cepa Root Chromosomal Aberration Assay: An Application in Assessing Anti-genotoxic Potential of Ashwagandha -- Withania somnifera: From Traditional Use to Evidence Based Medicinal Prominence -- Withanolides: A Prospective Drug for Infectious and Tropical Diseases -- Withania somnifera Extract/Withaferin A As A Prospective Anti-pigmenting Agent -- PART II Ashwagandha for Cancer -- Ashwagandha Bioactives for Cancer Treatment: Experimental Evidence and Their Mechanism(s) of Action -- Scientific Evidence for Anticancer Effects of Withania somnifera And its Primary Bioactive Component Withaferin A -- Withaferin A for Cancer Treatment: Experimental Evidence for its Effect on Telomerase Plus and Minus Cancer Cells -- Withania somnifera Has Potential to Treat Cancer -- The Effects of Withaferin A on Normal And Malignant Immune Cells -- Ashwagandha for Cancer Metastasis: Bioactives and Basics of their Function -- Computational Methods to Understand The Anticancer Mechanism of Withanolides -- PART III Ashwagandha for Brain -- Ashwagandha for Brain Health: Experimental Evidence to its Neuroregenerative Activities -- Cellular and Molecular Targets Underpinning Memory Enhancement by Ashwagandha -- Using Human Neural Stem Cells as A Model to Understand The Science of Ashwagandha -- The Potential Utility of Ashwagandha for Improving Cognitive Dysfunction in Persons with Bipolar or Other Neurocognitive Disorders -- Neuroprotective Potential of Withania somnifera (Ashwagandha) in Neurological Conditions -- Potential Therapeutic Use of Withania somnifera for Treatment of Amyotrophic Lateral Sclerosis -- Neuromodulatory Role of Withania somnifera -- Therapeutic Effects of Ashwagandha in Brain Aging and Clock Disfunction -- PART IV Active Ingredient Enriched Ashwagandha - Biotechnologies -- Biotechnological Approaches in Propagation And Improvement of Withania somnifera (L.) Dunal -- Plant Tissue Culture Based Strategies for Production of Withanolides -- Establishment of Hydroponic Cultivation of Ashwagandha for Active Ingredient Enriched Leaves.
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
|
0 |
|a Health promotion.
|
| 650 |
|
0 |
|a Medicine .
|
| 650 |
|
0 |
|a Health.
|
| 650 |
|
0 |
|a Medical education.
|
| 650 |
|
0 |
|a Complementary medicine.
|
| 650 |
1 |
4 |
|a Biomedicine, general.
|
| 650 |
2 |
4 |
|a Health Promotion and Disease Prevention.
|
| 650 |
2 |
4 |
|a Popular Science in Medicine and Health.
|
| 650 |
2 |
4 |
|a Medical Education.
|
| 650 |
2 |
4 |
|a Complementary & Alternative Medicine.
|
| 700 |
1 |
|
|a Kaul, Sunil C.
|e editor.
|
| 700 |
1 |
|
|a Wadhwa, Renu.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|